Cargando…
Soluble Klotho Improves Hepatic Glucose and Lipid Homeostasis in Type 2 Diabetes
Type 2 diabetes (T2D) is one of the most escalating global metabolic diseases, which is highly associated with insulin resistance (IR) and risk of combination with nonalcoholic fatty liver disease (NAFLD). Previous studies suggest that soluble klotho (sKL) could serve as a circulating hormone to med...
Autores principales: | Gu, Huiying, Jiang, Wei, You, Nan, Huang, Xiaobing, Li, Yuming, Peng, Xuehui, Dong, Rui, Wang, Zheng, Zhu, Yinan, Wu, Ke, Li, Jing, Zheng, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479259/ https://www.ncbi.nlm.nih.gov/pubmed/32953932 http://dx.doi.org/10.1016/j.omtm.2020.08.002 |
Ejemplares similares
-
A Nomogram Model for Predicting the Response to Transcatheter Arterial Embolization in Patients With Symptomatic Hepatic Hemangioma
por: Liu, Qinqin, et al.
Publicado: (2021) -
Upregulation of miR-181a impairs hepatic glucose and lipid homeostasis
por: Du, Xiliang, et al.
Publicado: (2017) -
Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma
por: Gu, Huiying, et al.
Publicado: (2020) -
Associations Between Serum Soluble α-Klotho and the Prevalence of Specific Cardiovascular Disease
por: Xu, Jun-Peng, et al.
Publicado: (2022) -
Soluble CLEC2 Extracellular Domain Improves Glucose and Lipid Homeostasis by Regulating Liver Kupffer Cell Polarization
por: Wu, Xinle, et al.
Publicado: (2015)